Science Explorer Back to mapMap
Discussion
Researcher · Reata Pharmaceuticals (United States) · United States

Joel W. Proksch

Joel W. Proksch publishes mostly in Molecular Biology, Ophthalmology and Pharmacology, on topics such as Ocular Infections and Treatments, Antibiotics Pharmacokinetics and Efficacy and Genomics, phytochemicals, and oxidative stress.

OpenAlex
World rank
#4,637,220
of 7,710,434 ranked researchers
Rank in United States
#1,225,322
of 1,627,098
Works
42
Citations
1.1k
Citations per work
25.2
h-index
20
i10-index 28Top 33% in Molecular Biology
Joel W. Proksch

What does Joel W. Proksch research?

Joel W. Proksch's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (5%).

Everything else: 16 works · 39.2% of their workHealth Sciences: 15 works · 35.8% of their workMedicine: 15 works · 35.8% of their workOphthalmology: 8 works · 18.3% of their workPharmacology: 3 works · 7.5% of their workDermatology: 2 works · 5.0% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 5.0% of their workLife Sciences: 10 works · 25.0% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 20.0% of their workMolecular Biology: 8 works · 20.0% of their workImmunology and Microbiology: 2 works · 5.0% of their workImmunology: 2 works · 5.0% of their workTHEIR WORKJoel W. Proksch42works
Life Sciences25%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1639.2%
    1. Medicine1535.8%
    1. Biochemistry, Genetics and Molecular Biology820.0%
    2. Immunology and Microbiology25.0%
  1. 1Molecular Biology20% of their works
  2. 2Ophthalmology18% of their works
  3. 3Pharmacology8% of their works
  4. 4Dermatology5% of their works
  5. 5Immunology5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging5% of their works

Research topics

Which keywords describe Joel W. Proksch's research?

The keywords of their largest research topics: Glaucoma, Antibiotic Pharmacokinetics, Critically Ill Patients, Endophthalmitis, Keratitis, Nrf2, Oxidative Stress and Signal Transduction.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glaucoma102 topics
  2. Antibiotic Pharmacokinetics91 topic
  3. Critically Ill Patients91 topic
  4. Endophthalmitis91 topic
  5. Keratitis91 topic
  6. Nrf281 topic
  7. Oxidative Stress81 topic
  8. Signal Transduction82 topics
  9. Cancer Therapy72 topics
  10. Femtosecond Laser61 topic
  11. Intraocular Lens Implantation61 topic
  12. Crystal Structure51 topic
  13. G-Protein-Coupled Receptors51 topic
  14. Chaperone41 topic
  15. Intraocular Pressure41 topic
  16. Optic Nerve41 topic
  17. Sigma-1 Receptor41 topic
  18. BRAF gene31 topic
  19. MAP Kinase31 topic

Where does Joel W. Proksch work?

Joel W. Proksch's main affiliation in the publication record is Reata Pharmaceuticals (United States), United States.

How many publications and citations does Joel W. Proksch have?

OpenAlex counts 42 works and 1,058 citations for Joel W. Proksch, an h-index of 20, ranking #4,637,220 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Joel W. Proksch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.